MétaCan
Menu
Back to cohort
Record W3137607562 · doi:10.1016/j.ekir.2021.02.041

Invasive Management of Coronary Artery Disease in Advanced Renal Disease

2021· review· en· W3137607562 on OpenAlexfundno aff
Keyvan Karimi Galougahi, Steven J. Chadban, Roxana Mehran, Sripal Bangalore, Glenn M. Chertow, Ziad A. Ali

Bibliographic record

VenueKidney International Reports · 2021
Typereview
Languageen
FieldMedicine
TopicChronic Kidney Disease and Diabetes
Canadian institutionsnot available
FundersNational Institute of Diabetes and Digestive and Kidney DiseasesData Science Institute, Columbia UniversityCanada Excellence Research Chairs, Government of CanadaJanssen Scientific AffairsIdorsia PharmaceuticalsSiemens Medical Solutions USABoston Scientific CorporationNational Institute of Allergy and Infectious DiseasesOrbusNeichBayerAmerican Medical AssociationChiesi FarmaceuticiBristol-Myers SquibbAstraZenecaCSL BehringNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationGilead SciencesMedtronicAbbott VascularAbbott Laboratories
KeywordsMedicineKidney diseaseCoronary artery diseaseIntensive care medicineDiseasePopulationRenal functionRandomized controlled trialInternal medicineEpidemiologyCardiology

Abstract

fetched live from OpenAlex

Coronary artery disease (CAD) is highly prevalent in chronic kidney disease (CKD). CKD modifies the effects of traditional risk factors on atherosclerosis, with CKD-specific mechanisms, such as inflammation and altered mineral metabolism, playing a dominant pathophysiological role as kidney function declines. Traditional risk models and cardiovascular screening tests perform relatively poorly in the CKD population, and medical treatments including lipid-lowering therapies have reduced efficacy. Clinical presentation of cardiac ischemia in CKD is atypical, whereas invasive therapies are associated with higher rates of complications than in with patients with normal or near normal kidney function. The main focus of the present review is on the invasive approach to management of CAD in late-stage CKD, with an in-depth discussion of the findings of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)-CKD trial, and their implications for therapeutic approach and future research in this area. We also briefly discuss the existing evidence in the epidemiology, pathogenesis, diagnosis, and medical management of CAD in late-stage CKD, end-stage kidney disease (ESKD), and kidney transplant recipients. We enumerate the evidence gap left by the frequent exclusion of patients with CKD from randomized controlled trials and highlight the priority areas for future research in the CKD population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.837
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.329
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueKidney International ReportsSame topicChronic Kidney Disease and DiabetesFrench-language works237,207